Chapter 18 Enhancement of Nerve Regeneration and Recovery by Immunosuppressive Agents

International Review of Neurobiology

Volumn 87, Issue C, 2009, Pages 347-362

  Kuffler, Damien P ^a  

^a UNIVERSITY OF PUERTO RICO MEDICAL SCIENCES CAMPUS   (Puerto Rico)

Author keywords

[No Author keywords available]

Indexed keywords

1 (3,3 DIMETHYL 1,2 DIOXOPENTYL) 2 PYRROLIDINECARBOXYLIC ACID 3 (3 PYRIDYL)PROPYL ESTER; ACTIVATING TRANSCRIPTION FACTOR 2; CYCLOPHILIN A; CYCLOSPORIN A; IMMUNOPHILIN; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PROTEOCHONDROITIN SULFATE; RAPAMYCIN; TACROLIMUS; CALCIUM;

ALLOGRAFT; ASTROCYTE; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; DRUG ACTIVITY; GENE REPRESSION; HUMAN; HYPOTHERMIA; IMMUNOSUPPRESSIVE TREATMENT; MENTAL DISEASE; METABOLIC DISORDER; MYELINATION; NEPHROTIC SYNDROME; NERVE FIBER REGENERATION; NERVE INJURY; NERVE SPROUTING; NERVE TRANSPLANTATION; NEUROPROTECTION; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; SCHWANN CELL; STROKE; XENOGRAFT; ANIMAL; BRAIN; CRYOANESTHESIA; DRUG EFFECT; METABOLISM; METHODOLOGY; NERVE FIBER; NERVE REGENERATION; PERIPHERAL NERVE; PHYSIOLOGY; SPINAL CORD; TIME;

ANIMALS; AXONS; BRAIN; CALCIUM; HUMANS; HYPOTHERMIA, INDUCED; IMMUNOPHILINS; IMMUNOSUPPRESSIVE AGENTS; NERVE REGENERATION; PERIPHERAL NERVES; SPINAL CORD; TACROLIMUS; TIME FACTORS;

EID: 70349786859     PISSN: 00747742     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0074-7742(09)87018-9     Document Type: Review

References (83)

1. Aghdasi B., Ye K., Resnick A., Huang A., Ha H.C., Guo X., Dawson T.M., Dawson V.L., and Snyder S.H. FKBP12, the 12-kda FK506-binding protein, is a physiologic regulator of the cell cycle. Proc. Natl. Acad. Sci. USA 98 (2001) 2425-2430
2. Avramut M., and Achim C.L. Immunophilins in nervous system degeneration and regeneration. Curr. Top. Med. Chem. 3 (2003) 1376-1382
3. Bain J.R. Peripheral nerve and neuromuscular allotransplantation: Current status. Microsurgery 20 (2000) 384-388
4. Bavetta S., Hamlyn P.J., Burnstock G., Lieberman A.R., and Anderson P.N. The effects of FK506 on dorsal column axons following spinal cord injury in adult rats: Neuroprotection and local regeneration. Exp. Neurol. 158 (1999) 382-393
5. Becker D.B., Jensen J.N., Myckatyn T.M., Doolabh V.B., Hunter D.A., and Mackinnon S.E. Effects of FKBP-12 ligands following tibial nerve injury in rats. J. Reconstr. Microsurg. 16 (2000) 613-620
6. Brandhorst G., Tenderich G., Zittermann A., Oezpeker C., Koerfer R., Oellerich M., and Armstrong V.W. Everolimus exposure in cardiac transplant recipients is influenced by concomitant calcineurin inhibitor. Ther. Drug Monit. 30 (2008) 113-116
7. Brenner M.J., Fox I.K., Kawamura D.H., Yu V.M., Lowe III J.B., Hunter D.A., and Mackinnon S.E. Delayed nerve repair is associated with diminished neuroenhancement by FK506. Laryngoscope 114 (2004) 570-576
8. Butcher S.P., Henshall D.C., Teramura Y., Iwasaki K., and Sharkey J. Neuroprotective actions of FK506 in experimental stroke: In vivo evidence against an antiexcitotoxic mechanism. J. Neurosci. 17 (1997) 6939-6946
9. Chabas J.F., Alluin O., Rao G., Garcia S., Lavaut M.N., Legre R., Magalon G., Marqueste T., Feron F., and Decherchi P. FK506 induces changes in muscle properties and promotes metabosensitive nerve fiber regeneration. J. Neurotraum 26 (2009) 97-108
10. Chen G.F., Gu L.Q., and Pei G.X. [Peripheral nerve regeneration under immunosuppression]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 16 (2002) 139-141
11. Chunasuwankul R., Ayrout C., Dereli Z., Gal A., Lanzetta M., and Owen E. Low dose discontinued FK506 treatment enhances peripheral nerve regeneration. Int. Surg. 87 (2002) 274-278
12. Cui Q., Hodgetts S.I., Hu Y., Luo J.M., and Harvey A.R. Strain-specific differences in the effects of cyclosporin A and FK506 on the survival and regeneration of axotomized retinal ganglion cells in adult rats. Neuroscience 146 (2007) 986-999
13. Du Y., Hirooka K., Miyamoto O., Itano T., Tokuda M., and Shiraga F. Both amacrine and bipolar cells release glutamate in the rat retina after ischemia/reperfusion insult in vitro. Curr. Eye Res. 33 (2008) 782-788
14. Fansa H., Keilhoff G., Altmann S., Plogmeier K., Wolf G., and Schneider W. The effect of the immunosuppressant FK 506 on peripheral nerve regeneration following nerve grafting. J. Hand Surg. (Br.) 24 (1999) 38-42
15. Fansa H., Keilhoff G., Horn T., Altmann S., Wolf G., and Schneider W. [Stimulation of Schwann cell growth and axon regeneration of peripheral nerves by the immunosuppressive drug FK 506]. Handchir. Mikrochir. Plast. Chir. 31 (1999) 323-329 discussion 330-322
16. Fry E.J., Ho C., and David S. A role for Nogo receptor in macrophage clearance from injured peripheral nerve. Neuron 53 (2007) 649-662
17. Fujita K., Kato T., Shibayama K., Imada H., Yamauchi M., Yoshimoto N., Miyachi E., and Nagata Y. Protective effect against 17beta-estradiol on neuronal apoptosis in hippocampus tissue following transient ischemia/recirculation in mongolian gerbils via down-regulation of tissue transglutaminase activity. Neurochem. Res. 31 (2006) 1059-1068
18. Furuichi Y., Maeda M., Matsuoka N., Mutoh S., and Yanagihara T. Therapeutic time window of tacrolimus (FK506) in a nonhuman primate stroke model: Comparison with tissue plasminogen activator. Exp. Neurol. 204 (2007) 138-146
19. Galat A. Functional drift of sequence attributes in the FK506-binding proteins (fkbps). J. Chem. Inf. Model. 48 (2008) 1118-1130
20. Ghazinezami B., Rahimpour S., Gholipour T., Ghasemi M., Sadeghipour H., Mehr S.E., Emami-Razavi S.H., and Dehpour A.R. Pharmacologic preconditioning of random-pattern skin flap in rats using local cyclosporine and FK-506: Interaction with nitric oxide system. Ann. Plast. Surg. 59 (2007) 435-440
21. Gillon R.S., Cui Q., Dunlop S.A., and Harvey A.R. Effects of immunosuppression on regrowth of adult rat retinal ganglion cell axons into peripheral nerve allografts. J. Neurosci. Res. 74 (2003) 524-532
22. Giordani F., Benetolli A., Favero-Filho L.A., Lima K.C., Cestari Junior L., and Milani H. Tacrolimus (FK506) reduces ischemia-induced hippocampal damage in rats: A 7- and 30-day study. Braz. J. Med. Biol. Res. 36 (2003) 495-502
23. Gold B.G., and Nutt J.G. Neuroimmunophilin ligands in the treatment of Parkinson's disease. Curr. Opin. Pharmacol. 2 (2002) 82-86
24. Gold R., and Schneider-Gold C. Current and future standards in treatment of myasthenia gravis. Neurotherapeutics 5 (2008) 535-541
25. Gold B.G., and Villafranca J.E. Neuroimmunophilin ligands: The development of novel neuroregenerative/neuroprotective compounds. Curr. Top. Med. Chem. 3 (2003) 1368-1375
26. Gold B.G., Zeleny-Pooley M., Chaturvedi P., and Wang M.S. Oral administration of a nonimmunosuppressant FKBP-12 ligand speeds nerve regeneration. Neuroreport 9 (1998) 553-558
27. Gold B.G., Densmore V., Shou W., Matzuk M.M., and Gordon H.S. Immunophilin FK506-binding protein 52 (not FK506-binding protein 12) mediates the neurotrophic action of FK506. J. Pharmacol. Exp. Ther. 289 (1999) 1202-1210
28. Gold B.G., Udina E., Bourdette D., and Navarro X. Neuroregenerative and neuroprotective actions of neuroimmunophilin compounds in traumatic and inflammatory neuropathies. Neurol. Res. 26 (2004) 371-380
29. Gold B.G., Armistead D.M., and Wang M.S. Non-FK506-binding protein-12 neuroimmunophilin ligands increase neurite elongation and accelerate nerve regeneration. J. Neurosci. Res. 80 (2005) 56-65
30. Grand A.G., Myckatyn T.M., Mackinnon S.E., and Hunter D.A. Axonal regeneration after cold preservation of nerve allografts and immunosuppression with tacrolimus in mice. J. Neurosurg. 96 (2002) 924-932
31. Gulati S., Prasad N., Sharma R.K., Kumar A., Gupta A., and Baburaj V.P. Tacrolimus: A new therapy for steroid-resistant nephrotic syndrome in children. Nephrol. Dial. Transplant 23 (2008) 910-913
32. Guzman-Lenis M.S., Vallejo C., Navarro X., and Casas C. Analysis of FK506-mediated protection in an organotypic model of spinal cord damage: Heat shock protein 70 levels are modulated in microglial cells. Neuroscience 155 (2008) 104-113
33. Hayashi Y., Shumsky J.S., Connors T., Otsuka T., Fischer I., Tessler A., and Murray M. Immunosuppression with either cyclosporine a or FK506 supports survival of transplanted fibroblasts and promotes growth of host axons into the transplant after spinal cord injury. J. Neurotrauma 22 (2005) 1267-1281
34. Hayashi A., Moradzadeh A., Tong A., Wei C., Tuffaha S.H., Hunter D.A., Tung T.H., Parsadanian A., Mackinnon S.E., and Myckatyn T.M. Treatment modality affects allograft-derived Schwann cell phenotype and myelinating capacity. Exp. Neurol. 212 (2008) 324-336
35. Iwasaki Y., Ichikawa Y., Igarashi O., Iwamoto K., Kinoshitata M., and Ikeda K. Neuroprotective actions of FK506 and cyclosporin A on motor neuron survival following neonatal axotomy. Neurol. Res. 24 (2002) 573-576
36. Jensen J.N., Brenner M.J., Tung T.H., Hunter D.A., and Mackinnon S.E. Effect of FK506 on peripheral nerve regeneration through long grafts in inbred swine. Ann. Plast. Surg. 54 (2005) 420-427
37. Jin K.B., Hwang E.A., Han S.Y., Park S.B., Kim H.C., Ha E.Y., Suh S.I., and Mun K.C. Effects of tacrolimus on antioxidant status and oxidative stress in glioma cells. Transplant. Proc. 40 (2008) 2740-2741
38. Kang C.B., Hong Y., Dhe-Paganon S., and Yoon H.S. FKBP family proteins: Immunophilins with versatile biological functions. Neurosignals 16 (2008) 318-325
39. Katsura K., Takahashi K., Asoh S., Watanabe M., Sakurazawa M., Ohsawa I., Mori T., Igarashi H., Ohkubo S., Katayama Y., and Ohta S. Combination therapy with transductive anti-death FNK protein and FK506 ameliorates brain damage with focal transient ischemia in rat. J. Neurochem. 106 (2008) 258-270
40. Keilhoff G., Langnaese K., Wolf G., and Fansa H. Inhibiting effect of minocycline on the regeneration of peripheral nerves. Dev. Neurobiol. 67 (2007) 1382-1395
41. Kihira T., Hironishi M., Utunomiya H., and Kondo T. FKBP12 immunoreactivity in the human spinal cord of motor neuron disease patients. Neuropathology 22 (2002) 269-274
42. Lagoda G., Sezen S.F., Liu T., Hoke A., and Burnett A.L. FK506-binding protein localizations in human penile innervation. BJU Int. 101 (2008) 604-609
43. Li X., Li H., Chen J., He Q., Lv R., Lin W., Li Q., He X., Qu L., and Suya W. Tacrolimus as a steroid-sparing agent for adults with steroid-dependent minimal change nephrotic syndrome. Nephrol. Dial. Transplant 23 (2008) 1919-1925
44. Lopez-Vales R., Garcia-Alias G., Fores J., Udina E., Gold B.G., Navarro X., and Verdu E. FK 506 reduces tissue damage and prevents functional deficit after spinal cord injury in the rat. J. Neurosci. Res. 81 (2005) 827-836
45. Lopez-Vales R., Fores J., Navarro X., and Verdu E. Olfactory ensheathing glia graft in combination with FK506 administration promote repair after spinal cord injury. Neurobiol. Dis. 24 (2006) 443-454
46. Manabe Y., Warita H., Murakami T., Shiote M., Hayashi T., Omori N., Nagano I., Shoji M., and Abe K. Early decrease of the immunophilin FKBP 52 in the spinal cord of a transgenic model for amyotrophic lateral sclerosis. Brain Res. 935 (2002) 124-128
47. Marcard T., Ivens K., Grabensee B., Willers R., Helmchen U., Rump L.C., and Blume C. Early conversion from cyclosporine to tacrolimus increases renal graft function in chronic allograft nephropathy at BANFF stages I and II. Transpl. Int. 21 (2008) 1153-1162
48. McKeon R.J., Schreiber R.C., Rudge J.S., and Silver J. Reduction of neurite outgrowth in a model of glial scarring following CNS injury is correlated with the expression of inhibitory molecules on reactive astrocytes. J. Neurosci. 11 (1991) 3398-3411
49. McKeon R.J., Hoke A., and Silver J. Injury-induced proteoglycans inhibit the potential for laminin-mediated axon growth on astrocytic scars. Exp. Neurol. 136 (1995) 32-43
50. Myckatyn T.M., Ellis R.A., Grand A.G., Sen S.K., Lowe III J.B., Hunter D.A., and Mackinnon S.E. The effects of rapamycin in murine peripheral nerve isografts and allografts. Plast. Reconstr. Surg. 109 (2002) 2405-2417
51. Nassar C.A., Nassar P.O., Andia D.C., Guimaraes M.R., Pepato M.T., and Spolidorio L.C. Biochemical evaluation of glycemic levels of long-term tacrolimus therapy in rats. Braz. Oral Res. 21 (2007) 293-297
52. Nilsson A., Skold K., Sjogren B., Svensson M., Pierson J., Zhang X., Caprioli R.M., Buijs J., Persson B., Svenningsson P., and Andren P.E. Increased striatal mRNA and protein levels of the immunophilin FKBP-12 in experimental Parkinson's disease and identification of FKBP-12-binding proteins. J. Proteome Res. 6 (2007) 3952-3961
53. Okajima S., Hojo T., Tamai K., Takai S., and Hirasawa Y. Histological and electrophysiological analysis of the peripheral nerve allografts using an immunosuppressive agent. Microsc. Res. Tech. 58 (2002) 52-58
54. Pan F., Chen A.M., Guo F.J., and Zhu C.L. [Effect of tacrolimus on apoptosis and expression of heat shock protein 70 after acute spinal cord injury in rats]. Zhonghua Wai Ke Za Zhi 44 (2006) 1708-1712
55. Reyes O., Sosa I., and Kuffler D.P. Neuroprotection of adult human neurons against ischemia by hypothermia and alkalinization. P. R. Health Sci. J. 25 (2006) 43-50
56. Rigol M., Solanes N., Sionis A., Galvez C., Martorell J., Rojo I., Brunet M., Ramirez J., Roque M., Roig E., Perez-Villa F., Barquin L., et al. Effects of cyclosporine, tacrolimus and sirolimus on vascular changes related to immune response. J. Heart Lung Transplant 27 (2008) 416-422
57. Rosenstiel P., Schramm P., Isenmann S., Brecht S., Eickmeier C., Burger E., Herdegen T., Sievers J., and Lucius R. Differential effects of immunophilin-ligands (FK506 and V-10,367) on survival and regeneration of rat retinal ganglion cells in vitro and after optic nerve crush in vivo. J. Neurotrauma 20 (2003) 297-307
58. Ross D.T., Guo H., Howorth P., Chen Y., Hamilton G.S., and Steiner J.P. The small molecule FKBP ligand GPI 1046 induces partial striatal re-innervation after intranigral 6-hydroxydopamine lesion in rats. Neurosci. Lett. 297 (2001) 113-116
59. Ruan B., Pong K., Jow F., Bowlby M., Crozier R.A., Liu D., Liang S., Chen Y., Mercado M.L., Feng X., Bennett F., von Schack D., et al. Binding of rapamycin analogs to calcium channels and FKBP52 contributes to their neuroprotective activities. Proc. Natl. Acad. Sci. USA 105 (2008) 33-38
60. Sarikcioglu L., Duygulu E., Aydin H., Gurer E.I., Ozkan O., and Tuzuner S. Effects of intrathecal administration of FK506 after sciatic nerve crush injury. J. Reconstr. Microsurg. 22 (2006) 649-654
61. Schwab J.M., Conrad S., Elbert T., Trautmann K., Meyermann R., and Schluesener H.J. Lesional rhoA + cell numbers are suppressed by anti-inflammatory, cyclooxygenase-inhibiting treatment following subacute spinal cord injury. Glia 47 (2004) 377-386
62. Seron D., O'Valle F., Moreso F., Goma M., Hueso M., Grinyo J.M., and Garcia del Moral R. Immunophenotype of infiltrating cells in protocol renal allograft biopsies from tacrolimus-versus cyclosporine-treated patients. Transplantation 83 (2007) 649-652
63. Silver J. Inhibitory molecules in development and regeneration. J. Neurol. 242 (1994) S22-S24
64. Srinivas T.R., and Meier-Kriesche H.U. Minimizing immunosuppression, an alternative approach to reducing side effects: Objectives and interim result. Clin. J. Am. Soc. Nephrol. 3 Suppl. 2 (2008) S101-S116
65. Sugawara T., Itoh Y., and Mizoi K. Immunosuppressants promote adult dorsal root regeneration into the spinal cord. Neuroreport 10 (1999) 3949-3953
66. Sulaiman O.A., Voda J., Gold B.G., and Gordon T. FK506 increases peripheral nerve regeneration after chronic axotomy but not after chronic schwann cell denervation. Exp. Neurol. 175 (2002) 127-137
67. Szydlowska K., Zawadzka M., and Kaminska B. Neuroprotectant FK506 inhibits glutamate-induced apoptosis of astrocytes in vitro and in vivo. J. Neurochem. 99 (2006) 965-975
68. Tanaka K., Fujita N., Asanuma M., and Ogawa N. Immunophilin ligands prevent H2O2-induced apoptotic cell death by increasing glutathione levels in neuro 2A neuroblastoma cells. Acta Med. Okayama 54 (2000) 275-280
69. Tashiro M., Dabrowski A., Guo L., Sans M.D., and Williams J.A. Calcineurin-dependent and calcineurin-independent signal transduction pathways activated as part of pancreatic growth. Pancreas 32 (2006) 314-320
70. Udina E., and Navarro X. [Immunophilins: Neuroprotective agents and promoters of neural regeneration]. Neurologia 17 (2002) 200-213
71. Udina E., Ceballos D., Verdu E., Gold B.G., and Navarro X. Bimodal dose-dependence of FK506 on the rate of axonal regeneration in mouse peripheral nerve. Muscle Nerve 26 (2002) 348-355
72. Udina E., Ceballos D., Gold B.G., and Navarro X. FK506 enhances reinnervation by regeneration and by collateral sprouting of peripheral nerve fibers. Exp. Neurol. 183 (2003) 220-231
73. Udina E., Voda J., Gold B.G., and Navarro X. Comparative dose-dependence study of FK506 on transected mouse sciatic nerve repaired by allograft or xenograft. J. Peripher. Nerv. Syst. 8 (2003) 145-154
74. Udina E., Verdu E., and Navarro X. Effects of the immunophilin ligand FK506 on nerve regeneration in collagen guides seeded with Schwann cells in rats. Neurosci. Lett. 357 (2004) 99-102
75. Valentine H., Chen Y., Guo H., McCormick J., Wu Y., Sezen S.F., Hoke A., Burnett A.L., and Steiner J.P. Neuroimmunophilin ligands protect cavernous nerves after crush injury in the rat: New experimental paradigms. Eur. Urol. 51 (2007) 1724-1731
76. Vinceti M., Bergomi M., Nacci G., Pietrini V., Ferrari A., Fortini K., Guidetti D., Sola P., Rocchi E., Mancia D., and Vivoli G. Erythrocyte zinc, copper, and copper/zinc superoxide dismutase and risk of sporadic amyotrophic lateral sclerosis: A population-based case-control study. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 3 (2002) 208-214
77. Voda J., Yamaji T., and Gold B.G. Neuroimmunophilin ligands improve functional recovery and increase axonal growth after spinal cord hemisection in rats. J. Neurotrauma 22 (2005) 1150-1161
78. Wang M.S., and Gold B.G. FK506 increases the regeneration of spinal cord axons in a predegenerated peripheral nerve autograft. J. Spinal Cord Med. 22 (1999) 287-296
79. Wang M.S., Zeleny-Pooley M., and Gold B.G. Comparative dose-dependence study of FK506 and cyclosporin A on the rate of axonal regeneration in the rat sciatic nerve. J. Pharmacol. Exp. Ther. 282 (1997) 1084-1093
80. Winter C., Schenkel J., Burger E., Eickmeier C., Zimmermann M., and Herdegen T. The immunophilin ligand FK506, but not GPI-1046, protects against neuronal death and inhibits c-Jun expression in the substantia nigra pars compacta following transection of the rat medial forebrain bundle. Neuroscience 95 (2000) 753-762
81. Wollenberg A., Reitamo S., Girolomoni G., Lahfa M., Ruzicka T., Healy E., Giannetti A., Bieber T., Vyas J., and Deleuran M. Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment. Allergy 63 (2008) 742-750
82. Yang R.K., Lowe III J.B., Sobol J.B., Sen S.K., Hunter D.A., and Mackinnon S.E. Dose-dependent effects of FK506 on neuroregeneration in a rat model. Plast. Reconstr. Surg. 112 (2003) 1832-1840
83. Zhang Z., Fauser U., and Schluesener H.J. Dexamethasone suppresses infiltration of rhoA + cells into early lesions of rat traumatic brain injury. Acta Neuropathol 115 (2008) 335-343